BMC Infectious Diseases

official impact factor 2.83

Open Access

Hepatic profile analyses of tipranavir in Phase II and III clinical trials

Jaromir Mikl*, Mark S Sulkowski, Yves Benhamou, Douglas Dieterich, Stanislas Pol, Jürgen Rockstroh, Patrick A Robinson, Mithun Ranga and Jerry O Stern

BMC Infectious Diseases 2009, 9:203 doi:10.1186/1471-2334-9-203

Accesses  

  • Last 30 days: 52 accesses
  • Last 365 days: 500 accesses
  • All time: 1848 accesses